Sector: Health Care
Director information for EMBECTA CORP (data for year 2025)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Bob J. Hombach | Chair | [] | [] | 2025 | |
| Carrie L. Anderson | Former Executive Vice President and Chief Financial Officer, The Campbell’s Company | 57 | ["financial expertise", "life sciences experience", "experience working with large, diversified global manufacturing companies", "executive leadership", "strategy and innovation", "risk and crisis management", "consumer/retail", "ESG", "experience with institutional investors"] | ["Audit", "Corporate Governance and Nominating"] | 2025 |
| Chrispher R. Reidy | [] | [] | 2025 | ||
| Christopher R. Reidy | Retired Executive Vice President, Chief Administrative Officer and Chief Financial Officer, Becton, Dickinson and Company (“BD”); Chair | 69 | [] | [] | 2025 |
| Claire Pomeroy, M.D. | President, The Albert and Mary Lasker Foundation | 70 | [] | [] | 2025 |
| Devdatt (Dev) Kurdikar | President and Chief Executive Officer, Embecta Corp. | 57 | ["experienced healthcare executive", "extensive experience in the medical device industry", "experience with global business, operations and manufacturing", "strategy and innovation", "cybersecurity and information systems", "risk and crisis management", "ESG", "regulatory and compliance matters", "experience with institutional investors"] | ["AdvaMed", "LMG Holdings", "Zimmer Biomet Holdings, Inc."] | 2025 |
| Dr. Claire Pomeroy | Chair; President of the Albert and Mary Lasker Foundation | 70 | ["expert in infectious diseases", "broad experience in healthcare delivery", "health system administration", "payer and medical reimbursement", "higher education", "medical research", "public health", "perspectives on patient care services", "global health", "health policy"] | ["Corporate Governance and Nominating", "Technology, Quality and Regulatory"] | 2025 |
| Dr. Milton M. Morris | [] | [] | 2025 | ||
| Dr. Morris | C-Suite Executive | 55 | ["Leadership experience in the medical industry", "Expertise in developing and successfully launching new medical device products", "Deep knowledge of the medical field", "Extensive experience in global business, operations and manufacturing, strategy and innovation, payer and medical reimbursement, risk and crisis management, regulatory and compliance matters, cybersecurity and information systems, as well as experience with institutional investors"] | ["Compensation and Management Development", "Technology, Quality and Regulatory"] | 2025 |
| Karen N. Prange | Industrial Advisor, EQT Group and Former Executive Vice President and Chief Executive Officer, Global Animal Health, Medical and Dental Surgical Group of Henry Schein, Inc. | 61 | ["public company governance experience", "leadership experience in the medical industry", "global business", "strategy and innovation", "payer and medical reimbursement", "risk management", "ESG", "regulatory and compliance experience"] | ["Compensation and Management Development (Chair)", "Corporate Governance and Nominating"] | 2025 |
| Milton M. Morris, Ph.D. | Former Chairman and Chief Executive Officer, Neuspera Medical, Inc. | 55 | [] | [] | 2025 |
| Mr. Hombach | Executive Vice President, Chief Financial Officer and Chief Operations Officer | 59 | ["financial expertise", "public company governance experience", "experience in the medical device industry", "experience with medical device technology", "experience with strategic and transactional transitions", "global business", "operations and manufacturing", "cybersecurity and information systems", "risk and crisis management", "experience with institutional investors", "payer and medical reimbursement experience"] | ["Audit (Chair)", "Compensation and Management Development Committee"] | 2025 |
| Mr. Reidy | Executive Vice President, Chief Administrative Officer | 69 | ["financial expertise", "leadership experience in the medical device industry", "extensive experience with medical device technology", "global business operations", "manufacturing", "strategy and innovation", "cybersecurity and information systems", "payer and medical reimbursement", "risk and crisis management", "consumer/retail", "ESG", "institutional investors"] | ["Technology, Quality and Regulatory (Chair)", "Audit"] | 2025 |
